SCHEMBL25357301

SCHEMBL25357301

NC(Cc1cccc(CNC(=O)N2CCN(CC(=O)O)CC2)c1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.50
▸ SLC7A5 Q01650 4/20 0.46
▸ TPSAB1 Q15661 1/20 0.44
▸ GRIA2 P42262 1/20 0.43
▸ ALPI P09923 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ PTGS1 P23219 1/20 0.43
▸ XIAP P98170 1/20 0.43
▸ HRH3 Q9Y5N1 1/20 0.42
▸ NOS3 P29474 2/20 0.42
▸ NOS1 P29475 2/20 0.42
▸ NOS2 P35228 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26009753 1.00 KDM4E (0.50) KDM4ESLC7A5TPSAB1GRIA2ALPI
SCHEMBL26009180 0.92 KDM4E (0.52) KDM4ESLC7A5TPSAB1GRIA2ALPI
SCHEMBL26009757 0.89 KDM4E (0.51) KDM4ESLC7A5TPSAB1ALPIPKM
SCHEMBL26008244 0.89 KDM4E (0.51) KDM4ESLC7A5TPSAB1ALPIPKM
SCHEMBL25356954 0.89 KDM4E (0.51) KDM4ESLC7A5TPSAB1ALPIPKM
SCHEMBL26009187 0.81 KDM4E (0.53) KDM4ESLC7A5TPSAB1ALPIPKM
SCHEMBL26008256 0.81 KDM4E (0.53) KDM4ESLC7A5TPSAB1ALPIPKM
SCHEMBL7108356 0.80 KDM4E (0.74) KDM4ETPSAB1HRH3MEN1LMNA
SCHEMBL7108298 0.79 KDM4E (0.72) KDM4ETPSAB1HRH3MEN1LMNA
SCHEMBL7412711 0.75 NAMPT (0.48) KDM4ESLC7A5ALPIPKMPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 — — US claimed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP KDM4E 4463/4885SLC7A5 21/4885TPSAB1 2973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback